GlassScriptPhysician profile
Tyler F Mayo
NPI 1720341209
$3,885.74
in general payments reported to CMS, 2019-2025
42 companies · $1,159 in 2025
The $1,159 reported for 2025 was more than what 88% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $272 · 2020: $385 · 2021: $404 · 2022: $451 · 2023: $435 · 2024: $780 · 2025: $1,159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,374.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,373.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $994.61 | 2021-2025 | |
| Vanda Pharmaceuticals INC. | $260.88 | 2024-2025 | Fanapt |
| Amgen INC. | $232.00 | 2019-2025 | Repatha, Otezla, Otezla |
| Lilly USA, LLC | $210.61 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $201.49 | 2019-2025 | Farxiga, Airsupra |
| Novo Nordisk INC | $195.20 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Allergan, INC. | $190.92 | 2019-2020 | |
| Pfizer INC. | $151.86 | 2020-2025 | |
| Teva Pharmaceuticals USA, INC. | $134.04 | 2019-2025 | Austedo Xr, Ajovy, Austedo Xr |
| Axsome Therapeutics, INC. | $113.14 | 2023-2025 | Auvelity |
| Glaxosmithkline, LLC. | $112.56 | 2019-2023 | Trelegy Ellipta |
| Viatris Specialty LLC | $82.43 | 2025 | Yupelri |
| Insulet Corporation | $72.86 | 2025 | Omnipod |
| Phathom Pharmaceuticals, INC. | $68.05 | 2025 | Voquezna |
| Boston Scientific Corporation | $66.49 | 2022-2025 | General - Pain Management, Watchman Flx |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Mayo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.